Literature DB >> 14051806

GROWTH INHIBITORY PROPERTIES OF MYCOPLASMA ANTIBODY.

J S BAILEY, H W CLARK, W R FELTS, T M BROWN.   

Abstract

Bailey, Jack S. (The George Washington University, Washington, D.C.), Harold W. Clark, William R. Felts, and Thomas McP. Brown. Growth inhibitory properties of Mycoplasma antibody. J. Bacteriol. 86:147-150. 1963.-A substance in antiserum responsible for growth inhibition of Mycoplasma was found to be associated with the water-insoluble globulin fraction. This fraction and the agglutinins removed from agglutinated antigen inhibited the growth of Mycoplasma in a similar manner. Sonic oscillation of antiserum broth cultures partially relieved the growth inhibition. The results of this study suggest the existence of neutralized Mycoplasma in a latent phase, which could explain their infrequent detection in tissues and fluids. The application of such techniques as sonic oscillation may improve the recovery and identification of Mycoplasma from these sources.

Entities:  

Keywords:  ANTIBODIES; MYCOPLASMA

Mesh：

Substances：

Year:  1963        PMID： 14051806      PMCID： PMC278386          DOI： 10.1128/jb.86.1.147-150.1963

Source DB:  PubMed          Journal:  J Bacteriol        ISSN： 0021-9193            Impact factor:   3.490


  6 in total

1.  Antigenic properties of pleuropneumonia-like organisms from tissue cell cultures and the human genital area.

Authors:  J S Bailey; H W Clark; W R Felts; R C Fowler; T M Brown
Journal:  J Bacteriol       Date:  1961-10       Impact factor: 3.490

2.  Stability of pleuropneumonialike organisms to some physical factors.

Authors:  P F SMITH; S SASAKI
Journal:  Appl Microbiol       Date:  1958-05

3.  Inhibition of growth of pleuropneumonia-like organisms by antibody.

Authors:  D G EDWARD; W A FITZGERALD
Journal:  J Pathol Bacteriol       Date:  1954-07

4.  Role of organisms of the pleuropneumonia group in human genital infections.

Authors:  C S NICOL; D G EDWARD
Journal:  Br J Vener Dis       Date:  1953-09

5.  Sonis reactivation of antiserum-neutralized bacteriophage T3.

Authors:  T F ANDERSON; A H DOERMANN
Journal:  J Bacteriol       Date:  1952-02       Impact factor: 3.490

6.  IDENTIFICATION OF MYCOPLASMATACEAE BY THE FLUORESCENT ANTIBODY METHOD.

Authors:  H W Clark; J S Bailey; R C Fowler; T M Brown
Journal:  J Bacteriol       Date:  1963-01       Impact factor: 3.490
  6 in total
  4 in total

1.  Modifications of the growth inhibition test and its application to human T-mycoplasmas.

Authors:  F T Black
Journal:  Appl Microbiol       Date:  1973-04

2.  A mechanistic approach to treatment of rheumatoid type arthritis naturally occurring in a gorilla.

Authors:  T M Brown; H W Clark; J S Bailey; C W Gray
Journal:  Trans Am Clin Climatol Assoc       Date:  1971

3.  A colour test for the measurement of antibody to certain mycoplasma species based upon the inhibition of acid production.

Authors:  D Taylor-Robinson; R H Purcell; D C Wong; R M Chanock
Journal:  J Hyg (Lond)       Date:  1966-03

4.  Some effects of growth medium composition on the antigenicity of a T-strain mycoplasma.

Authors:  G K Masover; R P Mischak; L Hayflick
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.